Evaluation of circulating tumor necrosis factor‐α in patients with gynecological malignancies
- 30 May 1991
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 48 (3) , 375-378
- https://doi.org/10.1002/ijc.2910480311
Abstract
TNF‐α levels in sera from patients with gynecological cancers were evaluated by ELISA and compared with those of patients with benign ovarian cysts or of anonymous healthy donors. Patients with cervical and endometrial carcinoma and with benign ovarian cysts showed levels of TNF‐α similar to those of healthy donors. In contrast, significantly increased levels of TNF‐α were found in patients with ovarian carcinoma, regardless of the stage of disease.Keywords
This publication has 24 references indexed in Scilit:
- In situ detection of tumour necrosis factor in human ovarian cancer specimensEuropean Journal of Cancer and Clinical Oncology, 1990
- In-vitro production of cytokines in serumThe Lancet, 1990
- The role of cachectin/TNF in endotoxic shock and cachexiaImmunology Today, 1988
- Extensive bone marrow necrosis in patients with cancer and tumor necrosis factor activity in plasmaAmerican Journal of Hematology, 1988
- Inhibition of cytotoxic T cell development by transforming growth factor beta and reversal by recombinant tumor necrosis factor alpha.The Journal of Experimental Medicine, 1987
- Effect of tumor necrosis factor alpha on mitogen-activated human B cells.The Journal of Experimental Medicine, 1987
- Cachectin: More Than a Tumor Necrosis FactorNew England Journal of Medicine, 1987
- Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1.The Journal of Experimental Medicine, 1986
- Purification and characterization of an immunosuppressive factor from ovarian cancer ascites fluidEuropean Journal of Immunology, 1981
- Tumor necrosis serum induces a serologically distinct population of NK cells.The Journal of Experimental Medicine, 1979